Analytical Data
-
基因名
ENA78
- Application
-
别名
ENA78；ENA78；C-X-C motif chemokine 5
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P42830
-
表达区间
41-114aa
-
氨基酸序列
AAVLRELRCVCLQTTQGVHPKMISNLQVFAIGPQCSKVEVVASLKNGKEI CLDPEAPFLKKVIQKILDGGNKEN
-
分子量
8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ENA78, also known as CXCL5, is a chemokine involved in inflammatory responses and immune regulation. It plays a crucial role in recruiting neutrophils to sites of injury or infection, making it vital for innate immunity. Research into ENA78 has gained momentum due to its implications in various pathological conditions, including cancer, respiratory diseases, and autoimmune disorders. Elevated levels of ENA78 have been associated with tumor progression and metastasis, as well as with chronic inflammatory diseases such as asthma and rheumatoid arthritis. The recombinant expression of ENA78 is essential for studying its biological functions and molecular mechanisms in detail. By producing ENA78 as a recombinant protein, researchers can investigate its structure, receptor interactions, and signaling pathways more effectively. Additionally, recombinant ENA78 can be used in therapeutic applications, providing potential avenues for developing novel treatments targeting ENA78-related pathways. Understanding ENA78’s role in inflammation and disease progression presents significant opportunities for therapeutic interventions aimed at modulating immune responses. Overall, the study of recombinant ENA78 is crucial for elucidating its functions in health and disease, highlighting its potential as a biomarker and therapeutic target.
